Subscribe
type here...
Subscribe

Tag: Stock Market News

Spero Therapeutics plummets 15% as FDA rejects new drug application

Global Markets Pharma -
Spero Therapeutics , Inc. shares plunged around 15% after-hours following the company’s announcement, according to which the U.S. Food...

Sutro Biopharma shares soar 67% due to cooperation with Astellas in cancer treatment

Global Markets Pharma -
Sutro Biopharma Inc. shares leaped 67% to $7.24 a share in U.S. after-hours trading after the South San Francisco...

Biotech investors focus on biotechs with drugs closer to market

Global Markets Pharma -
Biotech investors nursing losses from stock price falls are now focusing on firms which are closer to getting their...

ResApp stock returned from trading halt, down 29%

Global Markets Pharma -
The ResApp Health Ltd share price has returned from its trading halt and taken a tumble. In morning trade,...

Mereo BioPharma rises as AstraZeneca reportedly considers buying

Global Markets Pharma -
Shares of Mereo BioPharma (MREO), a small biotech company focused on developing therapies for cancer and rare diseases surged...

Pfizer to buy 8.1% stake in vaccines company Valneva

Global Markets Pharma -
U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1% percent stake...

Abbott infant formula plant closes again after severe storms and flooding, shares plummet

Global Markets Pharma -
Abbott Laboratories (ABT.N) has stopped production of the EleCare specialty baby formula at its plant in southwestern Michigan after...

GSK shares lost 3.85% in the last month

Global Markets Pharma -
In the latest trading session, GlaxoSmithKline (GSK) closed at $41.64, marking a -0.74% move from the previous day. This...

Valneva stocks fall as European deal on COVID vaccine flounders

Global Markets Pharma -
Valneva shed around a quarter of its market value on Monday after the French drugmaker warned that the future...

Hikma Pharmaceuticals down 30%, stock to buy on fall

EAEU Market Pharma -
Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was...

Cogent Biosciences begins $125 million public offering

Global Markets Pharma -
Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it...

Bluejay Diagnostics shares down 31% after rising Thursday

Global Markets Pharma -
Bluejay Diagnostics Inc. shares reversed course from Thursday's gains, dropping 31% to $1.12 one day after saying the Food...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026